Genovate Biotechnology Co Ltd (4130) — Free Cash Flow Generation Index
Genovate Biotechnology Co Ltd (4130) has a Free Cash Flow Generation Index of 0.52x as of December 2025. Free cash flow of NT$8.74 Million represents 1% of operating cash flow (NT$16.93 Million). Explore 4130 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genovate Biotechnology Co Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Genovate Biotechnology Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Genovate Biotechnology Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for Genovate Biotechnology Co Ltd. Check 4130 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.40x | NT$-17.63 Million | NT$43.79 Million | NT$61.42 Million | ▼ -193.4% |
| 2024 | 0.43x | NT$23.74 Million | NT$55.11 Million | NT$31.37 Million | ▼ -29.0% |
| 2023 | 0.61x | NT$51.44 Million | NT$84.78 Million | NT$33.34 Million | ▲ +104.1% |
| 2022 | -14.90x | NT$-22.50 Million | NT$1.51 Million | NT$24.01 Million | ▼ -2265.8% |
| 2020 | 0.69x | NT$59.92 Million | NT$87.08 Million | NT$27.01 Million | ▲ +91.5% |
| 2019 | 0.36x | NT$15.96 Million | NT$44.43 Million | NT$25.76 Million | ▼ -13.3% |
| 2018 | 0.41x | NT$26.07 Million | NT$62.88 Million | NT$35.26 Million | ▲ +276.5% |
| 2017 | -0.23x | NT$-7.34 Million | NT$31.27 Million | NT$38.53 Million | ▼ -114.9% |
| 2016 | 1.58x | NT$111.45 Million | NT$70.58 Million | NT$40.87 Million | ▼ -40.5% |
| 2015 | 2.65x | NT$86.28 Million | NT$32.53 Million | NT$53.75 Million | — |